Summary
There is currently no prospect of an end to the annual epidemics of acute bronchiolitis, which cause considerable morbidity in previously healthy infants and are a major threat to the well-being of infants with underlying cardiac, respiratory or immunological disease. The respiratory syncytial virus remains the major cause of this condition, and prospects of developing a vaccine remain bleak while our understanding of the viral-host interaction remain incomplete.
Treatment of patients with this condition has remained essentially unchanged for more than 30 years. Correction of hypoxia with oxygen, minimal handling to reduce the risk of exhaustion and careful noninvasive monitoring for complications such as apnoea and respiratory failure are the mainstays of management. Mortality in at-risk groups has fallen substantially during the past 10 years. This appears to be due to improved supportive and intensive care. The role of the antiviral agent ribavirin in the improved outcome, if any, is unclear. Other novel therapies have been tried, but none have been shown to significantly alter the natural history of the condition.
The only effective preventive intervention currently available is strict adherence to measures designed to prevent nosocomial infection. This condition is likely to remain a continuing challenge to paediatricians for the foreseeable future.
Article PDF
Similar content being viewed by others
References
Martin AJ, Gardner PS, McQuillin J. Epidemiology of respiratory viral infection among paediatric inpatients over a six year period in North East England. Lancet 1978; 2: 1035–8.
Glezen WP, Parades A, Allison JE, et al. Risk of respiratory syncytial virus infection for infants from low income families in relationship to age, sex, ethnic group and maternal antibody level. J Pediatr 1981; 98: 708–15.
Wileox MH, Williams O, Camp SJ, et al. Characteristics of successive epidemics of respiratory syncytial virus infection. Lancet 1991; 338: 943–4.
Hubble D, Osborn GR. Acute bronchiolitis in children. BMJ 1941; 1: 107–10.
Henry R, Milner AD, Stokes GM. Bronchiolitis [letter]. Am J Dis Child 1983; 137: 805.
Phelan PD, Landau LI, Olinsky A. Respiratory illness in children. Oxford: Blackwell Scientific Publications, 1990; 24–88.
Gardner PS. How etiological, pathological and clinical diagnoses can be made in a correlated fashion. Pediatr Res 1977; 11: 254–61.
Sims DG, Gardner PS, Weightman D, et al. Atropy does not predispose to RSV bronchiolitis or post bronchiolitic wheezing. BMJ 1981; 282: 2086–8.
Pullan CR, Hey EW. Wheezing, asthma and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. BMJ 1982; 284: 1665–9.
Carlsen KH, Larsen S, Bjerve O, et al. Acute bronchiolitis: predisposing factors and characterisation of infants at risk. Pediatr Pulmonol 1987; 3: 153–60.
McConnochie KM. Bronchiolitis. What is in a name? Am J Dis Child 1983; 137: 11–3.
Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Prob Pediatr 1993; 50–79.
Sporik R, Holgate ST, Cogswell JJ. Natural history of asthma in childhood — a birth cohort study. Arch Dis Child 1991; 66: 1050–3.
Wilson NM. Wheezy bronchitis revisited. Arch Dis Child 1989; 64: 1194–9.
Landau LI. Bronchiolitis and asthma: are they related? Thorax 1994; 49: 293–6.
Kim HW, Arrobio JO, Brandt CD, et al. Epidemiology of respiratory syncytial virus infection in Washington DC: 1. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 1973; 98: 216–25.
Murphy B, Phelan PD, Jack I, et al. Seasonal pattern of respiratory viral infection in children. Med J Aust 1980; 1: 22–4.
Hall CB, Geiman JM, Biggar R, et al. Respiratory syncytial virus infections within families. N Engl J Med 1976; 294: 414–9.
Fleming DM, Cross KW. Respiratory syncytial virus or influenza. Lancet 1993; 342: 1507–10.
Anderson LJ, Hierholzer JC, Tsou C, et al. Antigenic characterisation of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 1985; 151: 626–33.
Anderson LJ, Hendry, RM, Pierik LT, et al. Multicentre study of strains of respiratory syncytial virus. J Infect Dis 1991; 163: 687–92.
Hendry RM, Talis AL, Godfrey E, et al. Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis 1986; 153: 291–7.
Hall CB, Walsh EE, Long CE, et al. Immunity to and frequency of reinfection with respiratory syncytial virus. J Inf Dis 1991; 163: 693–8.
Everard ML, Milner AD. The respiratory syncytial virus and its role in acute bronchiolitis. Eur J Pediatr 1992; 151: 638–51.
Chanock RM, Kapikian AZ, Mills J, et al. Influence of immunological factors in respiratory syncytial virus disease of the lower respiratory tract. Arch Environ Health 1970; 21: 347–55.
Aherne W, Bird T, Court SDM, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23: 7–18.
Everard ML, Swarbrick A, Wrightman M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994; 71: 428–32.
Everard ML, Fox G, Walls AF, et al. Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis. Arch Dis Child 1995; 72: 64–9.
Turner RB. The role of neutrophils in the pathogenesis of rhinovirus infections. Pediatr Infect Dis J 1990; 9: 832–5.
Carr R, Pumford D, Davies JM. Neutrophil chemotaxis and adhesion in preterm babies. Arch Dis Child 1992; 67: 813–7.
Dos Santos C, Davidson D. Neutrophil chemotaxis to leukotriene B4 is decreased in the human neonate. Pediatr Res 1993; 33: 242–6.
Hall CB, Hopelman AE, Douglas RG, et al. Neonatal respiratory syncytial virus infections. N Engl J Med 1979; 300: 393–6.
Neligan GA, Steiner H, Gardner PS, et al. Respiratory syncytial virus infection of the newborn. BMJ 1970; 3: 146–7.
Church WR, Anas NG, Hall CB, et al. Respiratory syncytial virus related apnoea in infants. Am J Dis Child 1984; 138: 247–50.
Pickers DL, Schefft GL, Storch GA, et al. Characterisation of prolonged apnoeic episodes associated with respiratory syncytial virus infection. Pediatr Pulmonol 1989; 6: 195–201.
Parrott RH, Kim HW, Arrobio JO, et al. Epidemiology of respiratory syncytial virus infection in Washington DC: II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 1973; 98: 289–300.
Report to the Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines. Respiratory syncytial virus infection: admissions to hospital in industrial, urban and rural areas. BMJ 1978; 2: 796–8.
Green M, Brayer AF, Schenkman KA, et al. Duration of hospitalisation in previously well infants with respiratory syncytial virus infection. J Pediatr Infect Dis 1989; 8: 601–5.
Hall CB, Hall WJ, Speers DM. Clinical and physiological manifestations of bronchiolitis and pneumonia. Am J Dis Child 1979; 133: 798–802.
Lebel MH, Gauthier M, Lacroix J, et al. Respiratory failure and mechanical ventilation in severe bronchiolitis. Arch Dis Child 1989; 64: 1431–7.
McMillan JA, Tristram DA, Weiner LB, et al. Prediction of the duration of hospitilization in patients with respiratory syncytial virus infection: use of clinical parameters. Pediatrics 1988; 81: 22–6.
American Academy of Pediatrics. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 1993; 92: 501–4.
Stretton M, Ajizian SJ, Mitchell I, et al. Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol 1992; 13: 143–50.
Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 1992; 121: 348–54.
Meert K, Heidemann S, Lieh-Lai M, et al. Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol 1989; 7: 167–70.
Downham MAPS, Gardner PS, McQuillan J, et al. Role of respiratory viruses in childhood mortality. BMJ 1975; 1: 235–9.
Williams AL, Uren EC, Bretherton L. Respiratory viruses and sudden infant death. BMJ 1984; 299: 1491–3.
Anderson LJ, Parker RA, Strikas RL. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. J Infect Dis 1990; 161: 640–6.
Wang EEL, Milner RA, Navas L, et al. Observer agreement for respiratory signs and oximetry in infants hospitalized with respiratory infections. Am Rev Respir Dis 1992; 145: 106–9.
Shaw KN, Bell LM, Sherman NH. Outpatient assessment of infants with bronchiolitis. Am J Dis Child 1991; 145: 151–5.
Mulholland EK, Olinski A, Shann FA. Clinical findings and severity of acute bronchiolitis. Lancet 1990; 335: 1259–61.
Chonmaitree T, Bessette-Henderson BJ, Hepler RE, et al. Comparison of three rapid diagnostic techniques for detection of respiratory syncytial virus from nasal wash specimens. J Clin Microbiol 1987; 25: 746–7.
Hughes JH, Mann DR, Hamparian VV. Detection of respiratory syncytial virus in clinical specimens by viral culture, direct and indirect immunofluoresence and enzyme immunoassay. J Clin Microbiol 1988; 26: 588–91.
Dawson KP, Long A, Kennedy J, et al. The chest radiograph in acute bronchiolitis. J Paediatr Child Health 1990; 26: 209–11.
Friis B, Andersen P, Brenoe E, et al. Antibiotic treatment of pneumonia and bronchiolitis. Arch Dis Child 1984; 59: 1038–45.
Hall CB, Powell KR, Schnabel K, et al. The risk of secondary bacterial infection in infants hospitalised with respiratory syncytial virus infection. J Pediatr 1988; 113: 266–71.
Reynolds EOR, Cook CD. The treatment of bronchiolitis. J Pediatr 1963; 63: 1205–7.
Reynolds EOR. Arterial blood gas tensions in acute disease of lower respiratory tract in infancy. BMJ 1963; 1: 1192–5.
van Steensel-Moll HA, Hazelet JA, van der Voort E, et al. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child 1990; 65: 1237–9.
Sporik R. Why block a small hole? The adverse effects of nasogastric tubes. Arch Dis Child 1994; 71: 393–4.
Milner AD. Why block a small hole? Commentary. Arch Dis Child 1994; 71: 394.
Englund JA, Piedra PA, Ahn Y-M, et al. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1994; 125: 635–41.
Outwater KM, Meissner C, Peterson MB. Ribavirin administration to infants receiving mechanical ventilation. Am Dis Child 1988; 142: 512–5.
Janai HK, Marks MI, Zaleska RN, et al. Ribavirin: adverse drug reactions, 1986–1988. Pediatr Infect Dis J 1990; 9: 209–11.
Fackler JC, Flannery K, Zipkis M, et al. Precautions in the use of ribavirin at the children’s hospital. N Engl J Med 1990; 322: 634.
Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Ribavirin: is there a risk to hospital personnel? Can Med Assoc J 1991; 144: 285–6.
Conrad DA, Christenson JC, Waner JL, et al. Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic. Pediatr Infect Dis J 1987; 6: 152–8.
Wald ER, Dashefsky B, Green M. In re ribavirin: a case of premature adjudication? J Pediatr 1988; 112: 154–8.
Issacs D, Moxon ER, Harvey D, et al. Ribavirin in respiratory syncytial virus infection: a double blind placebo controlled trial is needed. Arch Dis Child 1988; 63: 986–90.
Ray CG. Ribavirin: ambivalence about an antiviral agent. Am J Dis Child 1988; 142: 488–9.
American Academy of Pediatrics Committee on Infectious Disease. Use of ribavirin in the treatment of respiratory syncytial infection. Pediatrics 1993; 92: 501–4.
Wald ER, Dashefsky B. Ribavirin. Red book committee reccommendations questioned. Pediatrics 1994; 93: 672–3.
Groothuis JR, Woodin KA, Katz R, et al. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr 1990; 117: 792–8.
MacDonald NE, Bresse Hall C, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982; 307: 397–400.
Moler FW, Khan AS, Meliones JN, et al. Respiratory syncytial virus morbidity and mortality in congenital heart disease patients: a recent experience. Crit Care Med 1992; 10: 1406–13.
Smith DW, Frankel LR, Mathers LH, et al. A controlled trial of aerosol ribavirin in infants receiving mechanical ventilation. N Engl J Med 1991; 325: 24–9.
Meert KL, Sarnik AP, Gelmini MJ, et al. Aerosolised ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective double blind trial. Crit Care Med 1994; 22: 566–71.
Outwater KM, Crone RK. Management of respiratory failure in infants with acute viral bronchiolitis. Am J Dis Child 1984; 138: 1071–5.
Frankel LR, Lewiston NJ, Smith DW, et al. Clinical observations on mechanical ventilation for respiratory failure in bronchiolitis. Pediatr Pulmonol 1986; 2: 307–11.
Njoku DB, Kliegman RM. Atypical extrapulmonary presentations of severe RSV infection requiring intensive care. Clin Pediatr 1993; 32: 455–60.
Rakshi K, Couriel JM. Personal practice: management of acute bronchiolitis. Arch Dis Child 1994; 71: 463–69.
Smith PJ, Khatib MF, Carlo W, PEEP does not improve pulmonary mechanics in infants with bronchiolitis. Am Rev Respir Dis 1993; 147: 1295–8.
Steinhorn RH, Green TP. Use of extracorporeal membrane oxygenation in thr treatment of respiratory syncytial virus bronchiolitis: the national experience, 1983–88. J Pediatr 1990; 116: 337–42.
Tristram DA, Miller RW, McMillan JA, et al. Simultaneous infection with respiratory syncytial virus and other respiratory pathogens. Am J Dis Child 1988; 142: 834–6.
Ray CG, Minnich LL, Holberg CJ, et al. Respiratory syncytial virus-associated lower respiratory illness: possible influences of other agents. Pediatr Infect Dis J 1993; 12: 15–9.
Marks MI. Respiratory syncytial virus infection: the expanded clinical spectrum. Clin Pediatr 1993; 32: 461–2.
La Via WW, Grant SW, Stutman HR, et al. Clinical profile of pediatric patients hospitalised with respiratory syncytial virus infection. Clin Pediatr 1993; 32: 450–4.
Milner AD, Murray M. Acute bronchiolitis in infancy; treatment and prognosis. Thorax 1989; 44: 1–5.
Archivist. Salbutamol in bronchiolitis. Arch Dis Child 1991; 66: 1183.
Goodman RT, Chambers TL. Bronchodilators for bronchiolitis? Lancet 1993; 341: 1380.
Phelan PD, Williams HE. Sympathomimetic drugs in acute viral bronchiolitis: their effect on pulmonary resistance. Pediatr 1969; 44: 493–7.
Rutter N, Milner AD, Hiller EJ. Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis. Arch Dis Child 1975; 50: 719–22.
Ho L, Collis G, Landau LI, et al. Effect of salbutamol on oxygen saturation in bronchiolitis. Arch Dis Child 1991; 66: 1061–4.
Hughes DM, Le Souef PN, Landau LI. Effect of salbutamol on respiratory mechanics in bronchiolitis. Pediatr Res 1987; 22: 83–6.
Brooks LJ, Cropp GJA. Theophylline therapy in bronchiolitis: a retrospective study. Am J Dis Child 1981; 135: 934–6.
Schena JA, Crone RK, Thompson JE. Theophylline therapy in bronchiolitis. Crit Care Med 1984; 12: 225.
Henry RL, Milner AD, Stokes GM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child 1983; 58: 925–6.
Wang EEL, Milner R, Allen U, et al. Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch Dis Child 1992; 67: 289–93.
Newcombe RW. Use of adrenergic bronchodilators by paediatric allergists and pulmonologists. Am J Dis Child 1989; 143: 481–5.
Sanchez I, De Koster J, Powell RE, et al. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics with bronchiolitis. J Pediatr 1993; 122: 145–51.
Schuh S, Canny G, Reisman JJ, et al. Nebulized albuterol in acute bronchiolitis. J Pediatr 1990; 117: 663–7.
Alario AJ, Leweander WJ, Dennehy P, et al. The efficacy of nebulised metaproterenol in wheezing infants and young children. Am J Dis Child 1992; 146: 412–8.
Klassen TP, Rowe PC, Sutcliffe T, et al. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991; 118: 807–11.
Schweich PJ, Hurt TL, Walkley EI, et al. The use of nebulized albuterol in wheezing infants. Pediat Emerg Care 1992; 8: 184–8.
Gadomski AM, Lichenstein R, Horton L, et al. Efficacy of albuterol in the management of bronchiolitis. Pediatr 1994; 93: 907–12.
Connolly JH, Field CMB, Glasgow JFT, et al. A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta Paediatr Scand 1969; 58: 116.
Leer JA, Green JL, Hemlich EM, et al. Corticosteriod treatment in bronchiolitis: a controlled collaborative study in 272 infants and children. Am J Dis Child 1969; 117: 495–503.
Committee on Drugs. Should steroids be used in treating bronchiolitis? Pediatr 1970; 46: 640–2.
Springer C, Bar-Yishay E, Uwayyed K, et al. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol 1990; 9: 181–5.
Webb MSC, Martin GA, Cartlidge PHJ, et al. Chest physiotherapy in acute bronchiolitis. Arch Dis Child 1985; 60: 1078–9.
Hemming VG, Rodriquez W, Kim HW, et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 1987; 31: 1882–6.
Levin MJ. Treatment and prevention options for respiratory syncytial virus infections. J Pediatr 1994; 124: S22–7.
Portnoy J, Hicks R, Pacheco F, et al. Pilot study of recombinant interferon Alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus. Antimicrob Agents Chemother 1988; 32: 589–91.
Gardner PS, Court SDM, Brocklebank JT, et al. Virus cross infection in paediatric wards. Br Med J 1973; 2: 571–5.
Hall CB, Douglas Jr GR, Geiman JM, et al. Nosocomial respiratory syncytial virus infections. N Engl J Med 1975; 293: 1343–6.
Hall CB, Douglas Jr RG. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99: 100–3.
Isaacs D, Dickson H, o’Callaghan CA, et al. Hand washing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child 1991; 66: 227–31.
o’Callaghan CA. Prevention of nosocomial respiratory syncytial virus infection. Lancet 1993; 341: 182.
Hall CB, Geiman JM, Douglas Jr GR, et al. Control of nosocomial respiratory syncytial viral infections. Pediatr 1978; 62: 728–31.
Gala CL, Hall CB, Schnabel KC, et al. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA 1986; 256: 2706–8.
Leclair JM, Freeman J, Sullivan BF, et al. Prevention of nosocomial respiratory syncytial virus infections through compliance with with glove and gown isolation precautions. N Engl J Med 1987; 317: 329–34.
Agah R, Cherry JD, Garakian AJ, et al. Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections. Am J Dis Child 1987; 141: 695–7.
Madge P, Paton JY, McColl JH, et al. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992; 340: 1079–83.
Kapikan AZ, Mitchell RH, Chanock RM, et al. An epidemiologic study of altered clinical reactivity to respiratory syncytial virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 1969; 89: 405–21.
Kim HW, Canchola JG, Brandt CD, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969; 89: 422–34.
Groothius JR, Simoes EAF, Levin JM, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993; 329: 1524–30.
McIntosh K. Respiratory syncytial virus — successful immunoprophylaxis at last. N Engl J Med 1993; 329: 1572–4.
Ellenberg SS, Epstein JS, Fratantoni JC, et al. A trial of RSV immune globulin in infants and young children: the FDA’s view. N Engl J Med 1994; 331: 203–4.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Everard, M.L. Bronchiolitis. Drugs 49, 885–896 (1995). https://doi.org/10.2165/00003495-199549060-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199549060-00003